Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2025-12-25 @ 4:33 PM
NCT ID: NCT00281957
Description: Regular investigator assessments are reported after each cycle of protocol treatment
Frequency Threshold: 5
Time Frame: While the patient is on treatment until resolution of acute toxicities with maximum grade reported
Study: NCT00281957
Study Brief: Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Arm I Sorafenib and Temsirolimu None None 13 63 61 63 View
Arm II Sorafenib and Tipifarnib None None 6 39 35 39 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Albumin, serum-low (hypoalbuminemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Ileus, GI (functional obstruction of bowel, i.e., neuroconstipation) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Infection with normal ANC or Grade 1 or 2 neutrophils - Nose SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (3.0) View
Infection with normal ANC or Grade 1 or 2 neutrophils - Skin (cellulitis) SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (3.0) View
Hemoglobin SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (3.0) View
Left ventricular systolic dysfunction SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE (3.0) View
Pain - Abdomen NOS SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Pancreatitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Fatigue (asthenia, lethargy, malaise) SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
Amylase SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Lipase SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Calcium, serum-low (hypocalcemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Glucose, serum-high (hyperglycemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Phosphate, serum-low (hypophosphatemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Potassium, serum-low (hypokalemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Muscle weakness, generalized or specific area (not due to neuropathy) - Whole body/generalized SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE (3.0) View
Pain - Back SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE (3.0) View
Pain - Joint SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE (3.0) View
Neurology-Other (Specify) SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE (3.0) View
Neuropathy: motor SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE (3.0) View
Pain - Head/headache SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE (3.0) View
Confusion SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE (3.0) View
Renal failure SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE (3.0) View
Pneumonitis/pulmonary infiltrates SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE (3.0) View
Pulmonary/Upper Respiratory-Other (Specify) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE (3.0) View
Pruritus/itching SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
Rash/desquamation SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
Flushing SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE (3.0) View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE (3.0) View
Thrombosis/thrombus/embolism SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE (3.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Pain - Muscle SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE (3.0) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE (3.0) View
Neuropathy: sensory SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE (3.0) View
Pain - Head/headache SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE (3.0) View
Taste alteration (dysgeusia) SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE (3.0) View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE (3.0) View
Mood alteration - depression SYSTEMATIC_ASSESSMENT Psychiatric disorders CTCAE (3.0) View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE (3.0) View
Dyspnea (shortness of breath) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE (3.0) View
Hemorrhage, pulmonary/upper respiratory - Nose SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE (3.0) View
Voice changes/dysarthria (e.g., hoarseness, loss or alteration in voice, laryngitis) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE (3.0) View
Dermatology/Skin-Other (Specify) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
Dry skin SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
Hair loss/Alopecia (scalp or body) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
Pruritus/itching SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
Rash/desquamation SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
Rash: acne/acneiform SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
Rash: hand-foot skin reaction SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
Flushing SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE (3.0) View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE (3.0) View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Mucositis/stomatitis (clinical exam) - Oral cavity SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Pain - Abdomen NOS SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Edema: limb SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
Fatigue (asthenia, lethargy, malaise) SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
Fever (in the absence of neutropenia, where neutropenia is defined as ANC lt1.0 x 10e9/L) SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
ALT, SGPT (serum glutamic pyruvic transaminase) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
AST, SGOT (serum glutamic oxaloacetic transaminase) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Alkaline phosphatase SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Bilirubin (hyperbilirubinemia) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Cholesterol, serum-high (hypercholesterolemia) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Creatinine SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Leukocytes (total WBC) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Lymphopenia SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Metabolic/Laboratory-Other (Specify) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Neutrophils/granulocytes (ANC/AGC) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Platelets SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Weight loss SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Albumin, serum-low (hypoalbuminemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Anorexia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Calcium, serum-low (hypocalcemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Glucose, serum-high (hyperglycemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Phosphate, serum-low (hypophosphatemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Potassium, serum-low (hypokalemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Sodium, serum-low (hyponatremia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Triglyceride, serum-high (hypertriglyceridemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Pain - Back SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE (3.0) View
Pain - Joint SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE (3.0) View
Hemoglobin SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (3.0) View